Viable Neuronopathic Gaucher Disease Model in Medaka (Oryzias latipes) Displays Axonal Accumulation of Alpha-Synuclein-Reference-Cited by-同舟云学术

Viable Neuronopathic Gaucher Disease Model in Medaka (Oryzias latipes) Displays Axonal Accumulation of Alpha-Synuclein

Published:2015-04-02 Issue:4 Volume:11 Page:e1005065
ISSN:1553-7404
Container-title:PLOS Genetics
language:en
Short-container-title:PLoS Genet

Author:

Uemura Norihito,Koike Masato,Ansai Satoshi,Kinoshita Masato,Ishikawa-Fujiwara Tomoko,Matsui Hideaki,Naruse Kiyoshi,Sakamoto Naoaki,Uchiyama Yasuo,Todo Takeshi,Takeda Shunichi,Yamakado Hodaka,Takahashi Ryosuke

Publisher

Public Library of Science (PLoS)

Subject

Cancer Research,Genetics (clinical),Genetics,Molecular Biology,Ecology, Evolution, Behavior and Systematics

Reference62 articles.

1. Gaucher disease;AH Futerman,2006

2. Phenotype, diagnosis, and treatment of Gaucher's disease;GA Grabowski;Lancet,2008

3. Neuropathology provides clues to the pathophysiology of Gaucher disease;K Wong;Mol Genet Metab,2004

4. Perinatal lethal Gaucher disease: a distinct phenotype along the neuronopathic continuum;MJ Eblan;Fetal Pediatr Pathol,2005

5. Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease;J Neumann;Brain,2009

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Experimental Parkinson models and green chemistry approach;Behavioural Brain Research;2024-08

2. Nanoparticles for inducing Gaucher disease-like damage in cancer cells;Nature Nanotechnology;2024-05-13

3. Current trends in basic research on Parkinson’s disease: from mitochondria, lysosome to α-synuclein;Journal of Neural Transmission;2024-04-13

4. A review on Gaucher disease: therapeutic potential of β-glucocerebrosidase-targeted mRNA/saRNA approach;International Journal of Biological Sciences;2024

5. Model Organisms Used in Aquatic Toxicology;Springer Water;2024